The Current Ratio as of September 2024 (TTM) for Anixa Biosciences, Inc. (ANIX) is 11.31

According to Anixa Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 11.31. This represents a change of -15.28% compared to the average of 13.35 of the last 4 quarters.

Anixa Biosciences, Inc. (ANIX) Historical Current Ratio (quarterly & annually)

How has ANIX Current Ratio performed in the past?

The mean historical Current Ratio of Anixa Biosciences, Inc. over the last ten years is 10.23. The current 11.31 Current Ratio has changed 10.96% with respect to the historical average. Over the past ten years (40 quarters), ANIX's Current Ratio was at its highest in in the July 2021 quarter at 30.67. The Current Ratio was at its lowest in in the January 2017 quarter at 0.56.

Anixa Biosciences, Inc. (ANIX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anixa Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anixa Biosciences, Inc. (ANIX) Average Current Ratio

How has ANIX Current Ratio performed in the past?

The current Current Ratio of Anixa Biosciences, Inc. (ANIX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Anixa Biosciences, Inc. (ANIX) Current Ratio vs. Peers

How is ANIX’s Current Ratio compared to its peers?

Anixa Biosciences, Inc.’s Current Ratio is greater than Cue Biopharma, Inc. (2.06), greater than INmune Bio, Inc. (2.36), greater than IN8bio, Inc. (2.66), greater than PolyPid Ltd. (0.95), greater than TFF Pharmaceuticals, Inc. (1.63), greater than Immunome, Inc. (7.12), greater than Annovis Bio, Inc. (1.24), greater than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (16.16), less than Rezolute, Inc. (11.82), greater than AN2 Therapeutics, Inc. (10.61), greater than Anebulo Pharmaceuticals, Inc. (5.32), greater than Mineralys Therapeutics, Inc. (11.20), greater than Arcellx, Inc. (6.01), less than PMV Pharmaceuticals, Inc. (19.22), less than Molecular Partners AG (14.58),

Build a custom stock screener for Anixa Biosciences, Inc. (ANIX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anixa Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anixa Biosciences, Inc. (ANIX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anixa Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.